Company news
Universal Ibogaine Inc (TSXV:IBO) news
Universal Ibogaine Inc news releases on 6ix. Latest, Feb 3, 2026: Canadian Investment Regulatory Organization Trading Halt - IBO
Press releases & updates
Canadian Investment Regulatory Organization Trading Halt - IBO
February 3, 2026
Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
January 19, 2026
Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
December 18, 2025
Universal Ibogaine advises further on application for Management Cease Trade Order
December 2, 2025
Universal Ibogaine Advises of Filing Application for Management Cease Trade Order
November 25, 2025
Universal Ibogaine Provides Corporate Update
October 28, 2025
Universal Ibogaine Announces Board Changes
September 23, 2025
Universal Ibogaine Announces Results of the Annual Meeting of Shareholders
September 14, 2025
Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply
September 4, 2025
Universal Ibogaine advises of appointment of two new Board Members
September 3, 2025
Universal Ibogaine advises of departure of CFO
July 16, 2025
Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors
July 7, 2025
Canadian Investment Regulatory Organization Trade Resumption - IBO
April 9, 2025
Universal Ibogaine Advises of Debt Settlement Agreement and Update on Status of Cease Trade Order
April 3, 2025
Universal Ibogaine Provides Update on Status of Current Cease Trade Order
February 5, 2025
Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings
January 27, 2025
Universal Ibogaine Announces Closing of Sale of Belize Property
January 22, 2025
Universal Ibogaine Provides Bi-weekly Status Report on Year-end Filings and update on Belize Property Sale
January 13, 2025
Universal Ibogaine Provides Bi-Weekly Default Status Report on Year-End Filings and Update on Belize Property Sale
December 27, 2024
Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings and update on pending sale of Belize property
December 12, 2024
Universal Ibogaine advises of Offer to purchase Belize property and update on application for Management Cease Trade Order
November 26, 2024
Universal Ibogaine Advises of Application for Management Cease Trade Order
November 18, 2024
Universal Ibogaine to Issue Common Shares Pursuant to Debt Settlement
June 17, 2024
Universal Ibogaine announces closing of private placement financing
June 7, 2024
Universal Ibogaine provides update on planned Clinical Trial Application process
April 29, 2024
Universal Ibogaine Announces Private Placement Financing and the Results of the Annual Meeting of Shareholders
April 22, 2024
Universal Ibogaine announces new private placement financing
April 12, 2024
Universal Ibogaine advises of management change
April 8, 2024
Universal Ibogaine Announces Additional Private Placement Financing
February 22, 2024
Universal Ibogaine Advises of Closing of Private Placement Financing
February 7, 2024
Universal Ibogaine provides final Bi-weekly Default Status Report on year-end and Q1 filings
February 2, 2024
Universal Ibogaine provides Bi-weekly Default Status Report and update on status of Private Placement
January 19, 2024
Universal Ibogaine provides Bi-weekly Default Status Report
January 5, 2024
Universal Ibogaine Advises of Appointment of New Auditors and Private Placement
December 21, 2023
Universal Ibogaine Announces Granting of Management Cease Trade Order
December 11, 2023
Universal Ibogaine provides update on prior application for Management Cease Trade Order
December 1, 2023
Universal Ibogaine Advises of Board Member Changes
October 12, 2023
Universal Ibogaine Engages Mike "Zappy" Zapolin as a Strategic Advisor
October 4, 2023
Universal Ibogaine Provides Corporate Update on Belize Property and Notice of Resignation of Auditors
September 6, 2023
Universal Ibogaine Advises of Update on the Status of Proposed Sale of Belize Island Property
June 7, 2023
Universal Ibogaine Announces Offering of Common Shares
May 19, 2023
Universal Ibogaine announces changes to its Board of Directors and addition to Advisory Board
May 9, 2023
TSX Venture Exchange Stock Maintenance Bulletins
April 14, 2023
Universal Ibogaine Announces Closing of Offering of Convertible Debt Securities
April 13, 2023
Universal Ibogaine announces agreement for the sale of Belize island property
March 30, 2023
Universal Ibogaine Announces Revision to Terms of Offering of Convertible Debt Securities
March 16, 2023
Universal Ibogaine Announces Offering of Convertible Debt Securities
February 6, 2023
Universal Ibogaine Announces Re-Opening of the Kelburn Recovery Center
January 23, 2023
Universal Ibogaine Highlights 2022 Accomplishments
January 4, 2023
Universal Ibogaine Issues Common Shares Pursuant to Settlement of Claim
December 9, 2022